Pharmacoangiography of the kidney: an overview.
The use of various vasoactive drugs in the angiographic investigation of renal pathology is discussed. It is concluded that vasoconstrictors (e.g., angiotensin) are to be preferred in order to demonstrate neovascularity, whereas vasodilators yield more information about "medical diseases" of the kidney. In spite of the increased use of noninvasive techniques such as ultrasound and computed tomography, it is suggested that pharmacoangiography will still remain a valuable tool in the diagnostic armamentarium of urologic radiologists.
D000109:Acetylcholine; D000293:Adolescent; D000328:Adult; D000804:Angiotensin II; D000818:Animals; D003287:Contrast Media; D004285:Dogs; D004837:Epinephrine; D006801:Humans; D007674:Kidney Diseases / Q000000981:diagnostic imaging*; D008297:Male; D011859:Radiography; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins
D003287:Contrast Media; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D014667:Vasopressins; D000804:Angiotensin II; D000109:Acetylcholine; D004837:Epinephrine